http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20010052866-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
| filingDate | 1999-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20010052866-A |
| titleOfInvention | Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3- ylidenemethyl)-cephems |
| abstract | The present invention provides a novel compound of formula (I), a pharmaceutically acceptable salt of said compound, and a hydrate of said compound and salts thereof; And the use of said compound, a pharmaceutically acceptable salt of said compound, and a hydrate of said compound and salts thereof for the preparation of a pharmaceutical formulation containing a compound of formula (I):n n n Formula In n n n n n n n [Wherein,n n n R 1 is hydrogen, C 1-6 alkyl optionally substituted with fluorine, or C 3-6 cycloalkyl,n n n R 2 is hydrogen or —CH 2 C (═CHR) —COOR, —CH 2 OCOR, —CH (R) OCOR, —CH (R) OCOOR, —CH (OCOR) OCOR, —CH 2 COCH 2 OCOR and A group selected from formula (II)n n n R 3 is hydrogen or -CH 2 C (= CH 2 ) -COOR, -COOCH 2 C (= CHR) -COOR, -COOCH 2 OCOR, -COOCH (R) OCOR, -COOCH (R) OCOOR, -COOCH (OCOR) OCOR, -COOCH 2 COCH 2 OCOR and a group selected from formula III, provided that one of R 2 and R 3 is hydrogen and the other is not hydrogen,n n n R is hydrogen or C 1-6 alkyl,n n n R 4 is hydrogen or hydroxy,n n n R 5 is hydrogen or ω-hydroxyalkyl,n n n X is CH or N]n n n Formula IIn n n n n n n n Formula IIIn n n n n n n n [Wherein R is hydrogen or C 1-6 alkyl]. |
| priorityDate | 1998-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.